Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.23.1
Equity Incentive Plan (Tables)
 3 Months Ended
Mar. 31, 2023
Equity Incentive Plan [Abstract]  
Schedule of share-based compensation expense
Stock Options & SARs   Three Months Ended 31,  
(in thousands)   2023     2022  
General and administrative   $ 234     $ 310  
Sales and marketing     59       28  
Research and development     91       65  
Cost of revenues     26       21  
    $ 410     $ 424  

 

RSUs   Three Months Ended 31,  
(in thousands)   2023     2022  
General and administrative   $ 123     $
-
  

 
Schedule of weighted average assumptions
    Three Months Ended
March 31,		  
    2023     2022  
Expected term (in years)     5.9       5.9  
Expected volatility     57.1 %     54.4 %
Risk-free rate     4.0 %     1.9 %
Dividend rate     —       —  

 
Schedule of stock option activity
Stock Option & SARs  

Number of

Shares under

Equity Plan

     Weighted-
Average
Exercise
Price per
Option		    

Weighted-

Average

Remaining

Contractual

Life
(in years)

  
Outstanding at December 31, 2022     8,234,823     $    1.82            7.7  
Granted     1,408,846     $ 1.75          
Exercised     (112,663 )   $ 0.76          
Forfeited and expired     (53,699 )   $ 2.38          
Outstanding at March 31, 2023     9,477,307     $ 1.81       7.9  
Exercisable at March 31, 2023     5,374,842     $ 1.52       7.0  
Vested and expected to vest at March 31, 2023     9,477,307     $ 1.81       7.9  

 

RSUs   Number of
Shares under
Equity Plan		     Weighted
Average
Grant Date
Fair Value		  
Outstanding at December 31, 2022     263,155     $ 1.90  
Granted    
-
     $
-
  
Exercised    
-
     $
-
  
Forfeited and expired    
-
     $
-
  
Outstanding at March 31, 2023     263,155     $ 1.90